NYSE:CVS - CVS Health Stock Price, News, & Analysis

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

CVS Health announced a quarterly dividend on Thursday, October 4th. Shareholders of record on Wednesday, October 24th will be given a dividend of $0.50 per share on Thursday, November 1st. This represents a $2.00 dividend on an annualized basis and a yield of 2.78%. The ex-dividend date is Tuesday, October 23rd. View CVS Health's Dividend History.

CVS Health Corp (NYSE:CVS) posted its quarterly earnings data on Tuesday, November, 6th. The pharmacy operator reported $1.73 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $1.71 by $0.02. The pharmacy operator had revenue of $47.27 billion for the quarter, compared to analyst estimates of $47.22 billion. CVS Health had a return on equity of 18.69% and a net margin of 1.65%. The firm's revenue was up 2.4% on a year-over-year basis. During the same period in the previous year, the firm earned $1.50 EPS. View CVS Health's Earnings History.

CVS Health is scheduled to release their next quarterly earnings announcement on Thursday, February 14th 2019. View Earnings Estimates for CVS Health.

CVS Health will be holding an earnings conference call on Wednesday, February 20th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

CVS Health issued an update on its FY18 earnings guidance on Tuesday, November, 6th. The company provided EPS guidance of $6.98-7.08 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $7.04. CVS Health also updated its FY 2018 guidance to $6.98-7.08 EPS.

19 brokers have issued 12 month price objectives for CVS Health's shares. Their forecasts range from $77.84 to $104.00. On average, they expect CVS Health's share price to reach $91.52 in the next twelve months. This suggests a possible upside of 27.3% from the stock's current price. View Analyst Price Targets for CVS Health.

19 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CVS Health in the last year. There are currently 3 hold ratings, 14 buy ratings and 2 strong buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CVS Health.

News stories about CVS stock have been trending somewhat positive recently, according to InfoTrie Sentiment. The research firm rates the sentiment of news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. CVS Health earned a news sentiment score of 1.2 on InfoTrie's scale. They also gave press coverage about the pharmacy operator a news buzz of 6.0 out of 10, meaning that recent news coverage is somewhat likely to have an effect on the stock's share price in the next several days.

CVS Health saw a decrease in short interest during the month of November. As of November 30th, there was short interest totalling 35,182,217 shares, a decrease of 41.2% from the November 15th total of 59,852,649 shares. Based on an average daily trading volume, of 10,480,873 shares, the days-to-cover ratio is presently 3.4 days. Currently, 2.7% of the company's shares are short sold. View CVS Health's Current Options Chain.

Some companies that are related to CVS Health include Walgreens Boots Alliance (WBA), Express Scripts (ESRX), Diplomat Pharmacy (DPLO), Rite Aid (RAD), 111 (YI), Petmed Express (PETS), Taxus Pharmaceuticals (TXSP), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP).

CVS Health's stock is owned by a number of of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (8.33%), Vanguard Group Inc (8.33%), BlackRock Inc. (7.48%), FMR LLC (2.95%), Dodge & Cox (1.48%) and Dodge & Cox (1.48%). Company insiders that own CVS Health stock include Andrew Sussman, C David Brown II, David M Denton, Eva C Boratto, Helena Foulkes, Jonathan C Roberts, Kevin Hourican, Larry J Merlo, Lisa Bisaccia, Richard J Swift, Thomas M Moriarty and Troyen A Brennan. View Institutional Ownership Trends for CVS Health.

CVS stock was sold by a variety of institutional investors in the last quarter, including Capital Research Global Investors, The Manufacturers Life Insurance Company, Mitsubishi UFJ Trust & Banking Corp, State Treasurer State of Michigan, Swedbank, PGGM Investments, Clearbridge Investments LLC and Bridgewater Associates LP. Company insiders that have sold CVS Health company stock in the last year include David M Denton, Eva C Boratto, Helena Foulkes, Kevin Hourican, Lisa Bisaccia and Troyen A Brennan. View Insider Buying and Selling for CVS Health.

CVS stock was acquired by a variety of institutional investors in the last quarter, including Dodge & Cox, Dodge & Cox, Capital International Investors, Diamond Hill Capital Management Inc., BlackRock Inc., Vanguard Group Inc, Vanguard Group Inc. and Senator Investment Group LP. View Insider Buying and Selling for CVS Health.

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of CVS stock can currently be purchased for approximately $71.88.

CVS Health has a market capitalization of $74.75 billion and generates $184.77 billion in revenue each year. The pharmacy operator earns $6.62 billion in net income (profit) each year or $5.90 on an earnings per share basis. CVS Health employs 246,000 workers across the globe.

The official website for CVS Health is http://www.cvshealth.com.

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]